TNFAIP3 and systemic sclerosis: To further probe parallels in the gene expression changes in bleomycin-treated A20+/− mice and SSc patients, we performed the same cross-species analysis using a set of genes regulated by bleomycin in wild-type (A20fl/fl) mice.